NEUROPSYCHOLOGICAL STATE OF POST-COVID PATIENTS

Abstract
The purpose of this review is to summarize and analyze published literature data during the COVID-19 pandemic on possible pathogenetic mechanisms for the development of neuropsychiatric and cognitive impairments (CI) in patients with coronavirus infection. According to currently available data, SARS-CoV-2 can affect every organ in the body, leading to acute damage and long-term consequences, with the latter effects becoming apparent only recently.
Keywords
COVID-19, SARS-CoV-2, coronavirus, psychoneuroimmunology, cognitive impairment.
References
- Mao L., Wang M., Chen S. et al., Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. URL: https://www.medrxiv.org/content/10.1101/2020.02.22.20026500v1
- Baig A.M., Khaleeq A., Ali U. et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020; 11(7): 995–8. DOI: 10.1021/acschemneuro.0c00122
- Wong A.M., Simon E.M., Zimmerman R.A. et al. Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. Am. J. Neuroradiol. 2006; 27(9): 1919–23.
- Ahmed M.Z., Ahmed O., Aibao Z. et al. Epidemic of COVID19 in China and associated psychological problems. Asian J. Psychiatr. 2020; 51: 102092. DOI: 10.1016/j.ajp.2020.102092
- [Maltseva M.N., Shmonin A.A., Melnikova E.V. et al. Assistance to patients with behavioral and psychological problems receiving treatment for coronavirus infection (COVID-2019) in a pandemic. Bulletin of Rehabilitation Medicine. 2020; 97(3): 105–109. (in Russian)]. DOI: 10.38025/2078-1962-2020-97-3-105-109
- Alonso-Lana S., Marquie M., Ruiz A. et al. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front. Aging Neurosci. 2020; 12: 588872. DOI: 10.3389/fnagi.2020.588872
- Zhang K., Zhou X., Liu H. et al. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders. Br. J. Psychiatry. 2020; 217(1): 351. DOI: 10.1192/bjp.2020.84
Downloads
Download data is not yet available.